Next Generation Sequencing (NGS) Markets 2015 (Systems,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends)

Dublin, Feb. 23, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/b3...generation ) has announced the addition of the "Next Generation Sequencing (NGS) Markets 2015 (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Platforms, Applications, Brand Ownership and Other Trends)" report to their offering.

No business planner in biotechnology or diagnostic equipment or services can ignore the trend of sequencing, and particularlynext-generation sequencing. This technology has enabled a wide scope of research and genetic analysis. The promise of DNA sequencing has attracted many companies, researchers, and investors. DNA sequencing has already become a large market, and clinical applications of DNA sequencing are being developed and commercialized. More than ever, marketers of advanced equipment and those investing in those companies need a resource to identify the specific developments in sequencing.

This report, Next-Generation Sequencing Markets (Systems, Consumables, Services, Acquisitions, Agreements, Competitive Analysis, Trends, Platforms, Applications, Brand Ownership) provides evidence of the promise and current excitement in the DNA sequencing market.

Evidence of the promise and current excitement with DNA sequencing can be seen with many recent events:

  • The DNA sequencing market is growing rapidly. In October 2014, market leader Illumina raised the company's full year 2014 guidance for investors to a revenue growth for the company of approximately 30% over the previous year.
  • Roche and Foundation Medicine announced an agreement that is worth up to $1.2 billion. Roche agreed to acquire a majority interest in Foundation Medicine for approximately $780 million. Roche also agreed to invest $250 million in Foundation Medicine, and to fund potentially more than $150 million of R&D
  • Companies are raising money: In just the first part of January 2015, In addition to Roche's investment in Foundation Medicine, 10X Genomics closed a $55.5 million Series B financing and Invitae filed for an initial public offering, These follow a busy 2014 year that saw many investments in next generation sequencing companies and companies with products or services related to next generation sequencing.
  • Agreements with pharmaceutical companies: Companies in the pharmaceutical industry have recognized the potential benefits of next generation sequencing as a research and development tool. During just part of 2015, Genentech announced two agreements, and Pfizer announced one.
  • Sequencing companies are starting to develop and commercialize kits that can be produced and sold to clinical laboratories following the traditional in vitro diagnostic (IVD) model. Illumina's MiSeqDx was the first cleared in vitro diagnostic (IVD) next generation sequencing system. MiSeqDx is also CE marked, and FDA-cleared tests are currently available on this platform.

Key Topics Covered:

One: Executive Summary

Two: Introduction

Three: Sequencing Technology

Four: Sequencing Applications

Five: Deals - Sequencing Companies

Six: Applying Sequencing To Diagnostics - Market Drivers And Challenges

Seven: Dna Sequencing Market Analysis

Eight: Company Profiles: Next Generation Sequencing Companies

  • 10X Genomics
  • 23andMe, Inc.
  • Adaptive Biotechnologies Corporation
  • Admera Health (A GENEWIZ Company)
  • Advanced Biological Laboratories, S.A
  • Agilent Technologies Inc.
  • AltheaDx Diagnostics, Inc.
  • Ambry Genetics Corp.
  • Aperiomics, Inc.
  • Appistry, Inc.
  • Asuragen, Inc.
  • Diagnostic Products
  • Genomic Services
  • Clinical Lab
  • Companion Diagnostics
  • Athena Diagnostics, Inc. (A Quest Diagnostics Business)
  • Base4 Innovation Ltd
  • Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
  • Next-Generation Sequencing - Sample Prep
  • Beckman Coulter Genomics
  • BGI-Shenzhen
  • Bina Technologies, Inc. (Acquired by Roche)
  • BioDiscovery, Inc.
  • Bioinnovation Solutions SA
  • Biomatters Ltd.
  • bioMérieux SA
  • bioTheranostics (A bioMérieux Company)
  • Cancer Genetics, Inc.
  • CareDx, Inc.
  • Caris Life Sciences
  • Chronix Biomedical, Inc.
  • CLC bio (A QIAGEN Company)
  • Complete Genomics (A BGI Company)
  • Courtagen Life Sciences, Inc.
  • Cypher Genomics, Inc
  • DioGenix, Inc.
  • DNA Electronics Ltd.
  • DNASTAR, Inc.
  • Eurofins Genomics
  • Eurofins MWG Operon Inc. (A Eurofins Genomics Company)
  • Expression Analysis, Inc. (A Quintiles Company)
  • Fluidigm Corporation
  • Foundation Medicine, Inc.
  • GATC Biotech AG
  • GenapSys
  • GenDx
  • Gene by Gene, Ltd.
  • Genection, Inc. (An Invivoscribe Company)
  • GeneDx
  • GeneInsight, Inc.
  • GENEWIZ Inc.
  • Genia Technologies, Inc. (Acquired by Roche)
  • GenoLogics Life Sciences Software
  • Genomic Diagnostics Technologies
  • GenomOncology
  • Genoptix (A Novartis Company)
  • GigaGen, Inc.
  • GnuBIO, Inc. (Acquired by Bio-Rad Laboratories, Inc.)
  • Good Start Genetics, Inc.
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • Igenbio, Inc.
  • Illumina, Inc.
  • Innovations Exchange Pte Ltd (INEX)
  • iGene Diagnostics Pte Ltd (an INEX Company)
  • Insight Genetics, Inc.
  • InSilixa, Inc.
  • Intel Corporation
  • Intelligent Bio-Systems, Inc. (A QIAGEN Company)
  • Invitae Corporation
  • Invivoscribe Technologies, Inc.
  • iRepertoire, Inc.
  • Knome Inc.
  • Laboratory Corporation of America (LabCorp)
  • LaserGen, Inc.
  • LifeCodexx AG (Subsidiary of GATC Biotech AG)
  • Life Technologies Corporation (Acquired by Thermo Fischer Scientific Inc.)
  • Mayo Medical Laboratories and Mayo Clinic
  • MolecularMD Corporation
  • Multiplicom NV
  • Nabsys, Inc.
  • Natera, Inc.
  • NeoGenomics, Inc./NeoGenomics Laboratories
  • NetBio, Inc
  • NewGene Ltd.
  • NextCODE Health
  • NobleGen Biosciences, Inc.
  • N-of-One, Inc.
  • OncoDNA SA
  • OncoPlex Diagnostics (OncoPlexDx)
  • Oncospire Genomics
  • One Lambda, Inc. (A Thermo Fisher Scientific Brand)
  • Oxford Gene Technology
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences
  • Parabase Genomics
  • Pathway Genomics Corporation
  • PerkinElmer, Inc.
  • Personal Genome Diagnostics, Inc.
  • Personalis, Inc.
  • PicoSeq
  • Population Genetics Technologies Ltd
  • QIAGEN N.V.
  • QuantuMDx Group
  • Quest Diagnostics
  • RainDance Technologies, Inc.
  • Response Genetics, Inc.
  • Roche
  • SeqLL, LLC
  • Sequenta, Inc
  • Siemens Healthcare Diagnostics
  • Siemens
  • Sirona Genomics
  • SoftGenetics, LLC
  • Stratos Genomics Inc.
  • Swift Biosciences, Inc.
  • Symbiodx
  • Sysmex Inostics GmbH
  • Thermo Fisher Scientific, Inc.
  • Vela Diagnostics
  • WaferGen Biosystems, Inc.
  • ZS Genetics, Inc.

For more information visit http://www.researchandmarkets.com/research/b3...generation



CONTACT: CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biotechnology

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 360

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 519

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 55

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 349

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 113

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 328

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 79

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

Venezuela's Political Shift and Its Impact on Global Oil Markets

Updated Category News Views 122

Venezuela's Dramatic Political Changes and Market Reactions Recent events in Venezuela have created quite a stir. With the U.S. capturing Nicolás Maduro, the country's president, and extraditing him for trial, one might expect a major upheaval in financial and commodity markets. Surprisingly, the markets seem largely unaffected by this significant geopolitical shift....

Continue Reading
Paradigm Health Pushes Innovative FDA Trial Initiative

Updated Category News Views 27

The FDA's Real-Time Game Changer Just up and submitting their convincing response to the FDA, Paradigm Health's grabbing headlines with a trailblazing initiative right out of Columbus, Ohio. The FDA's Real-Time Clinical Trials (RTCT) proof-of-concept has been a field where Paradigm wields its AI-driven wand, proposing a plan that promises to streamline clinical trial...

Continue Reading
DSV A/S Launches Major Share Buyback Program Announcement

Updated Category News Views 74

DSV A/S Launches Major Share Buyback Program Company Announcement No. 1130 In a strategic effort to boost shareholder value, DSV A/S has launched a share buyback program. This initiative officially began on July 24, 2024, and is expected to wrap up on October 22, 2024. The company plans to repurchase its own shares totaling up to DKK 1,500 million, which corresponds to a...

Continue Reading
Insights into the Growth of the Global Fondant Market Trends

Updated Category News Views 230

Exploring the Global Fondant Market Trends The fondant market is rapidly evolving, driven by a surge in consumer preferences for aesthetically pleasing dessert options. Recent research identifies that the fondant market size, valued at approximately USD 520.45 Million, is anticipated to reach around USD 898.79 Million by 2034, reflecting a robust compound annual growth...

Continue Reading
Innocan Pharma's Strategic Move: Private Placement Details

Updated Category News Views 110

Innocan Pharma's Exciting Private Placement Initiative Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) has announced a significant financial move by planning a non-brokered private placement. This initiative aims to issue up to 3,500,000 units, priced at C$0.20 each, bringing in gross proceeds of up to C$700,000. This offering is designed to expedite the...

Continue Reading